02/27/2024 3:42 PM | Bitterman Robert J (Reporting) Phio Pharmaceuticals Corp. (Issuer) Phio Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 6:00 PM | Bitterman Robert J (Reporting) Phio Pharmaceuticals Corp. (Issuer) Phio Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 6:03 PM | Kontulis Caitlin (Reporting) Phio Pharmaceuticals Corp. (Issuer) Phio Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2024 9:30 AM | INTRACOASTAL CAPITAL, LLC (Filed by) Phio Pharmaceuticals Corp. (Subject) Phio Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/28/2023 8:13 AM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form 424B3 | |
12/27/2023 11:15 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form EFFECT | |
12/19/2023 3:52 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
|
12/19/2023 12:07 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form D Notice of Exempt Offering of Securities | |
12/08/2023 4:00 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/03/2023 6:00 PM | Bitterman Robert J (Reporting) Phio Pharmaceuticals Corp. (Issuer) Phio Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/29/2023 3:30 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/21/2023 6:30 AM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/20/2023 8:30 AM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form 424B3 | |
06/19/2023 11:15 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form EFFECT | |
06/13/2023 3:40 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form D Notice of Exempt Offering of Securities | |
06/09/2023 3:31 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form DEFA14A | |
06/09/2023 3:32 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form ARS | |
06/02/2023 3:30 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/01/2023 4:00 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form 424B5 | |
05/24/2023 6:35 AM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/16/2023 6:35 AM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/11/2023 4:01 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/11/2023 4:02 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/10/2023 3:30 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form 424B3 | |
05/09/2023 11:15 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form EFFECT | |
04/20/2023 4:22 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/20/2023 1:53 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/20/2023 1:55 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form 424B3 | |
04/20/2023 1:56 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form 424B3 | |
04/20/2023 1:57 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form 424B3 | |
04/20/2023 1:57 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form 424B3 | |
04/20/2023 1:58 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form 424B3 | |
04/20/2023 1:59 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form 424B3 | |
04/19/2023 4:06 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form 424B5 | |
04/18/2023 6:55 AM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/17/2023 4:25 PM | Phio Pharmaceuticals Corp. (Filer) Phio Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |